{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:11:05Z","timestamp":1774465865465,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-023-02199-7","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T02:01:36Z","timestamp":1699495296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Aristotelis","family":"Kalyvas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao Paulo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"O\u2019Halloran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"W\u00e4lchli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent C.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranay","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamia","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun R.","family":"Kshettry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo F.","family":"Recinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"1","key":"2199_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8(1):3\u20136","journal-title":"Pituitary"},{"issue":"5","key":"2199_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524","journal-title":"JAMA"},{"issue":"3","key":"2199_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","volume":"41","author":"T Mindermann","year":"1994","unstructured":"Mindermann T, Wilson CB (1994) Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 41(3):359\u2013364","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2199_CR4","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J et al (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84(7):2518\u20132522","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2199_CR5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3171\/2010.11.JNS101369","volume":"114","author":"MC Oh","year":"2011","unstructured":"Oh MC, Aghi MK (2011) Dopamine agonist-resistant prolactinomas. J Neurosurg 114(5):1369\u20131379","journal-title":"J Neurosurg"},{"issue":"1","key":"2199_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-019-02076-8","volume":"67","author":"E Nevzati","year":"2020","unstructured":"Nevzati E et al (2020) Surgical management considerations in cystic prolactinomas-a single center case series. Endocrine 67(1):58\u201366","journal-title":"Endocrine"},{"issue":"1","key":"2199_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","volume":"8","author":"DK Hamilton","year":"2005","unstructured":"Hamilton DK et al (2005) Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary 8(1):53\u201360","journal-title":"Pituitary"},{"issue":"3","key":"2199_CR8","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH et al (2020) Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J Clin Endocrinol Metabol 105(3):e32\u2013e41","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"2199_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2199_CR10","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/jc.2007-0836","volume":"92","author":"JA Schlechte","year":"2007","unstructured":"Schlechte JA (2007) Long-term management of prolactinomas. J Clin Endocrinol Metab 92(8):2861\u20132865","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2199_CR11","first-page":"1006","volume":"62","author":"AR Dehdashti","year":"2008","unstructured":"Dehdashti AR et al (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62(5):1006\u20131015 discussion 1015-7","journal-title":"Neurosurgery"},{"key":"2199_CR12","first-page":"1","volume":"132","author":"AS Little","year":"2019","unstructured":"Little AS et al (2019) Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) study. J Neurosurg 132:1\u201311","journal-title":"J Neurosurg"},{"issue":"3","key":"2199_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1749-4486.2011.02331.x","volume":"36","author":"JK Goudakos","year":"2011","unstructured":"Goudakos JK, Markou KD, Georgalas C (2011) Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol 36(3):212\u2013220","journal-title":"Clin Otolaryngol"},{"issue":"11","key":"2199_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","volume":"22","author":"TR Smith","year":"2015","unstructured":"Smith TR et al (2015) Current indications for the surgical treatment of prolactinomas. J Clin Neurosci 22(11):1785\u20131791","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2199_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","volume":"158","author":"S Akin","year":"2016","unstructured":"Akin S et al (2016) Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases. Acta Neurochir (Wien) 158(5):933\u2013942","journal-title":"Acta Neurochir (Wien)"},{"issue":"45","key":"2199_CR16","doi-asserted-by":"publisher","first-page":"e13198","DOI":"10.1097\/MD.0000000000013198","volume":"97","author":"YL Han","year":"2018","unstructured":"Han YL et al (2018) Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery. Medicine (Baltimore) 97(45):e13198","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2199_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12020-018-1652-y","volume":"62","author":"N Yi","year":"2018","unstructured":"Yi N et al (2018) Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery. Endocrine 62(1):76\u201382","journal-title":"Endocrine"},{"issue":"4","key":"2199_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/s-0037-1615748","volume":"79","author":"F Yoo","year":"2018","unstructured":"Yoo F et al (2018) Comparison of male and female prolactinoma patients requiring surgical intervention. J Neurol Surg B Skull Base 79(4):394\u2013400","journal-title":"J Neurol Surg B Skull Base"},{"issue":"4","key":"2199_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/neuros\/nyy385","volume":"85","author":"A Micko","year":"2019","unstructured":"Micko A et al (2019) Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria. Neurosurgery 85(4):508\u2013515","journal-title":"Neurosurgery"},{"issue":"5","key":"2199_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF et al (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489\u2013498","journal-title":"Pituitary"},{"issue":"4","key":"2199_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.nec.2019.05.004","volume":"30","author":"M Marigil Sanchez","year":"2019","unstructured":"Marigil Sanchez M et al (2019) Management of giant pituitary adenomas: role and outcome of the endoscopic endonasal surgical approach. Neurosurg Clin N Am 30(4):433\u2013444","journal-title":"Neurosurg Clin N Am"},{"issue":"aop","key":"2199_CR22","first-page":"1","volume":"1","author":"M Lang","year":"2018","unstructured":"Lang M et al (2018) Superiority of constructive interference in steady-state MRI sequencing over T1-weighted MRI sequencing for evaluating cavernous sinus invasion by pituitary macroadenomas. J Neurosurg 1(aop):1\u20138","journal-title":"J Neurosurg"},{"issue":"1","key":"2199_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2199_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11102-018-0907-1","volume":"21","author":"T Cesak","year":"2018","unstructured":"Cesak T et al (2018) Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review. Pituitary 21(6):561\u2013570","journal-title":"Pituitary"},{"issue":"6","key":"2199_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/qjmed\/hcs240","volume":"106","author":"P Iglesias","year":"2013","unstructured":"Iglesias P, Diez JJ (2013) Macroprolactinoma: a diagnostic and therapeutic update. QJM 106(6):495\u2013504","journal-title":"QJM"},{"issue":"11","key":"2199_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jocn.2009.03.024","volume":"16","author":"B Bahuleyan","year":"2009","unstructured":"Bahuleyan B et al (2009) Non-surgical management of cystic prolactinomas. J Clin Neurosci 16(11):1421\u20131424","journal-title":"J Clin Neurosci"},{"key":"2199_CR27","doi-asserted-by":"publisher","unstructured":"Petersenn S et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol\u00a0https:\/\/doi.org\/10.1038\/s41574-023-00886-5","DOI":"10.1038\/s41574-023-00886-5"},{"issue":"5","key":"2199_CR28","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.fertnstert.2015.07.1132","volume":"104","author":"G Vila","year":"2015","unstructured":"Vila G et al (2015) Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril 104(5):1210\u20137 e1","journal-title":"Fertil Steril"},{"issue":"3","key":"2199_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","volume":"14","author":"M Babey","year":"2011","unstructured":"Babey M et al (2011) Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14(3):222\u2013230","journal-title":"Pituitary"},{"issue":"9","key":"2199_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.clineuro.2013.02.016","volume":"115","author":"H Ikeda","year":"2013","unstructured":"Ikeda H et al (2013) Transsphenoidal microsurgical results of female patients with prolactinomas. Clin Neurol Neurosurg 115(9):1621\u20131625","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"2199_CR31","first-page":"21557","volume":"8","author":"Z Yan","year":"2015","unstructured":"Yan Z et al (2015) Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period. Int J Clin Exp Med 8(11):21557\u201321564","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"2199_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535","journal-title":"Acta Neuropathol"},{"issue":"11","key":"2199_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00701-003-0134-y","volume":"145","author":"S Wolfsberger","year":"2003","unstructured":"Wolfsberger S et al (2003) Microprolactinomas in males treated by transsphenoidal surgery. Acta Neurochir (Wien) 145(11):935\u2013940 discussion 940-1","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"2199_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/EJE-10-0961","volume":"164","author":"X Qu","year":"2011","unstructured":"Qu X et al (2011) Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases. Eur J Endocrinol 164(4):499\u2013504","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2199_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"Primeau V, Raftopoulos C, Maiter D (2012) Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166(5):779\u2013786","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2199_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3171\/2018.5.JNS18595","volume":"131","author":"S Cohen-Cohen","year":"2018","unstructured":"Cohen-Cohen S et al (2018) The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients. J Neurosurg 131(1):131\u2013140","journal-title":"J Neurosurg"},{"issue":"1","key":"2199_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-016-1115-2","volume":"55","author":"L Andereggen","year":"2017","unstructured":"Andereggen L et al (2017) 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine 55(1):223\u2013230","journal-title":"Endocrine"},{"key":"2199_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.wneu.2016.10.059","volume":"97","author":"L Andereggen","year":"2017","unstructured":"Andereggen L et al (2017) Long-term follow-up of primary medical versus surgical treatment of prolactinomas in men: effects on hyperprolactinemia, hypogonadism, and bone health. World Neurosurg 97:595\u2013602","journal-title":"World Neurosurg"},{"issue":"7","key":"2199_CR39","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","volume":"87","author":"M Losa","year":"2002","unstructured":"Losa M et al (2002) Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome. J Clin Endocrinol Metab 87(7):3180\u20133186","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2199_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EJE-14-0990","volume":"172","author":"E Delgrange","year":"2015","unstructured":"Delgrange E et al (2015) Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. Eur J Endocrinol 172(6):791\u2013801","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2199_CR41","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1159\/000358673","volume":"33","author":"D Dai","year":"2014","unstructured":"Dai D et al (2014) GAL3 protein expression is related to clinical features of prolactin-secreting pituitary microadenoma and predicts its recurrence after surgical treatment. Cell Physiol Biochem 33(4):1026\u20131035","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"2199_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1012905415868","volume":"54","author":"P Nomikos","year":"2001","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2001) Current management of prolactinomas. J Neurooncol 54(2):139\u2013150","journal-title":"J Neurooncol"},{"issue":"Supplement","key":"2199_CR43","first-page":"S92","volume":"68","author":"JP Almeida","year":"2020","unstructured":"Almeida JP et al (2020) The importance of long term follow up after endoscopic pituitary surgery: durability of results and tumor recurrence. Neurol India 68(Supplement):S92\u2013S100","journal-title":"Neurol India"},{"issue":"2","key":"2199_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11102-011-0348-6","volume":"15","author":"LJ Sheplan Olsen","year":"2012","unstructured":"Sheplan Olsen LJ et al (2012) Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 15(2):135\u2013145","journal-title":"Pituitary"},{"issue":"2","key":"2199_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1227\/01.NEU.0000223445.22938.BD","volume":"59","author":"N Pouratian","year":"2006","unstructured":"Pouratian N et al (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59(2):255\u2013266 discussion 255-66","journal-title":"Neurosurgery"},{"issue":"6","key":"2199_CR46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s11102-015-0658-1","volume":"18","author":"O Cohen-Inbar","year":"2015","unstructured":"Cohen-Inbar O et al (2015) Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results. Pituitary 18(6):820\u2013830","journal-title":"Pituitary"},{"key":"2199_CR47","first-page":"1","volume":"133","author":"YC Hung","year":"2019","unstructured":"Hung YC et al (2019) The benefit and risk of stereotactic radiosurgery for prolactinomas: an international multicenter cohort study. J Neurosurg 133:1\u201310","journal-title":"J Neurosurg"},{"issue":"262","key":"2199_CR48","first-page":"145","volume":"70","author":"MD Littley","year":"1989","unstructured":"Littley MD et al (1989) Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70(262):145\u2013160","journal-title":"Q J Med"},{"issue":"4","key":"2199_CR49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0360-3016(94)90346-8","volume":"30","author":"JT Parsons","year":"1994","unstructured":"Parsons JT et al (1994) Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30(4):755\u2013763","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2199_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","volume":"21","author":"G Minniti","year":"2016","unstructured":"Minniti G et al (2016) Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Rep Pract Oncol Radiother 21(4):370\u2013378","journal-title":"Rep Pract Oncol Radiother"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02199-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02199-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02199-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T18:18:01Z","timestamp":1705947481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02199-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02199-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pablo Recinos is a consultant for Stryker, and Varun Kshettry is a consultant for Stryker and Integra LifeSciences. The aforementioned disclosures are not relevant to this work. The rest of the authors report no competing interests regarding the materials or methods used in this study or the findings specified in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of both institutions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A waiver of subject consent was approved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"295"}}